Omeros Corporation (OMER)

NASDAQ
7.13
-0.07(-0.97%)
After Hours
6.80
-0.33(-4.63%)
- Real-time Data
  • Volume:
    644,919
  • Day's Range:
    7.04 - 7.46
  • 52 wk Range:
    1.86 - 16.57

OMER Overview

Prev. Close
7.2
Day's Range
7.04-7.46
Revenue
58.82M
Open
7.24
52 wk Range
1.86-16.57
EPS
3.1
Volume
644,919
Market Cap
447.27M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,478,567
P/E Ratio
-2.25
Beta
1.13
1-Year Change
-53.28%
Shares Outstanding
62,730,015
Next Earnings Date
Nov 10, 2022
What is your sentiment on Omeros?
or
Market is currently closed. Voting is open during market hours.

Omeros Corporation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Omeros Corporation Analysis

Omeros Corporation Company Profile

Omeros Corporation Company Profile

Employees
213

Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic diseases, including complement-mediated diseases and cancers related to dysfunction of the immune system, as well as addictive and compulsive disorders. Its lead lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA). Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, atypical hemolytic uremic syndrome, and COVID-19. OMS906, its inhibitor of MASP-3, an activator of the alternative pathway of complement, is initiating a Phase I b clinical program in paroxysmal nocturnal hemoglobinuria (PNH).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellBuyStrong BuySell
Technical IndicatorsStrong SellNeutralSellStrong BuyStrong Sell
SummaryStrong SellNeutralNeutralStrong BuyStrong Sell
  • This was added at $ 6,25 based on the run to the north.
    0
    • This is just getting started folks.
      0
      • Well, It appers iits not ready to turn around. Based on what I see: The STOCH is starting to build momentum on the hourly; however, I would keep an eye out on the RSI, as this still does not have any strength. The Range I will be watching is bollinger bands: Low: $11.09 Mid:17.34. I will be holding to see whats going to take place. It appears a level of support is around $13.14. I am still in this trade, and I am learning to watch the stocks versus jumping into something that doesn't prove to have support just yet. It sure is a lot cheaper to watch versus throw in and cross fingers it will hold.
        1
        • down %12 good buy for small amount of shares?
          1
          • good buy or avoid?
            1
            • Based on what i see were in a up trend approaching a channel resistance of about $19. Im holding
              0
              • based on yesterday's slowness, I'm kinda hesitant to play with it. any suggestion gurus?
                0
                • Sell or hold???
                  0
                  • This thing going to ****up soon
                    0
                    • extremely undervalued, 9.4m shorts slowing it down. slow and steady is fine
                      0